Skip to main navigation Skip to search Skip to main content

Evaluating mechanotransduction inhibitors as a potential treatment strategy for aggressive breast cancers

Project Details

StatusActive
Effective start/end date3/2/26 → 2/26/27

Funding

  • New Jersey Health Foundation, Inc. (NJHF): $50,000.00